Watch Demo

Canada Analgesic Industry Outlook 2022 - 2026

See how Canada Analgesic performed compared to key markets such as Germany and Spain.

Key Market Indicators

Sales of analgesic medicines in Canada are expected to reach $681 million by 2026, down from $786 million in 2021. That's an average year-on-year decrease of 1.8%. Since 2017, the Canadian market has seen an average annual decline of 1.4%. In 2021, Canada was ranked third among countries with the highest analgesic sales, behind Spain and Italy. Spain held the top spot with $786 million, followed by Canada at $786 million and Italy at $786 million.

Marketing Banner

Canada Analgesic Market Data and Forecasts

How much will Canada Analgesic Market grow to 2026?

Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Canada
Forecast: Analgesic Medicine Sales in Canada
Forecast: Analgesic Medicine Sales in Canada
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Canada
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Canada
More in Analgesic Industry for 2028

Improve your Knowledge with the latest Indicators and Trends